Overview

Pentoxifylline in Diabetic Kidney Disease

Status:
Recruiting
Trial end date:
2030-07-08
Target enrollment:
Participant gender:
Summary
Pentoxifylline (PTX) is a medication that has been on the market since 1984 for use in disease in the blood vessels of the legs. There is some preliminary information that it may protect the kidneys from damage due to diabetes and other diseases. "Pentoxifylline in Diabetic Kidney Disease" is a study to bee conducted in 40 VA hospitals across the nation to determine definitively whether or not PTX can prevent worsening of kidney disease and delay death in patients with diabetic kidney disease.
Phase:
Phase 4
Details
Lead Sponsor:
VA Office of Research and Development
Treatments:
Pentoxifylline